Drug GMP definition high priority for Sept. MRA joint sectoral agenda committee meeting.
This article was originally published in The Tan Sheet
Executive Summary
DRUG GMP DEFINITION TO BE ON MRA JOINT SECTORAL AGENDA as a top priority at the scheduled September meeting of the Joint Sectoral Committee established under the U.S.-European Union Mutual Recognition Agreement to assist in the implementation and monitoring of the agreement. As drafted, the MRA calls for a "tentative merging" of U.S. and European Commission "concepts to be revisited" regarding methods to be used in, and the facilities and controls to be used for, the manufacturing, processing, packing and/or holding of a drug product.